Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EPHEYL: Étude PHarmacoÉpidémiologique de l'hYperparathyroïdie Secondaire en Lorraine

NCT02888639 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.

NCT NCT02888639
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02888639 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EPHEYL: Étude PHarmacoÉpidémiologique de l'hYperparathyroïdie Secondaire en Lorraine
Lead sponsor
Central Hospital, Nancy, France
Phase
Observational
Overall status
Completed
Start date
December 31, 2009
Completion date
May 31, 2012
Enrollment
305 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

esrd